GlassScriptPhysician profile
Stacy Tsai
NPI 1366897456
$2,788.11
in general payments reported to CMS, 2019-2025
16 companies · $1,385 in 2025
The $1,385 reported for 2025 was more than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $191 · 2021: $436 · 2022: $160 · 2023: $149 · 2024: $295 · 2025: $1,385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,268 · Travel and Lodging: $562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,267.66 |
| Travel and Lodging | $561.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $947.46 | 2025 | |
| Pfizer INC. | $563.04 | 2020-2022 | |
| Abbott Laboratories | $468.95 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $135.56 | 2024-2025 | Lifevest |
| Medtronic, INC. | $116.07 | 2021 | |
| Alnylam Pharmaceuticals INC. | $108.77 | 2024 | Onpattro |
| Cvrx, INC. | $101.02 | 2025 | Barostim Neo System |
| Amgen INC. | $56.66 | 2023 | Repatha |
| Astrazeneca Pharmaceuticals LP | $47.99 | 2020-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $47.98 | 2023 | Arcalyst |
| Kestra Medical Technology Services, INC. | $45.24 | 2024 | Assure Wcd |
| Endotronix, INC. | $44.33 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| E.R. Squibb & Sons, L.L.C. | $38.96 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $23.50 | 2023 | Verquvo |
| Regeneron Healthcare Solutions, INC. | $21.84 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $20.74 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Tsai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.